The cumulative incidence of any major eye disease end point (PDR, CSME, application of laser, or development of blindness) is shown in relation to diabetes.

Slides:



Advertisements
Similar presentations
For(int i = 1; i
Advertisements

“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.
Diabetic Microvascular Disease: The Role of Glycemic Control and the Impact on Public Health Robert E. Ratner, MD MedStar Research Institute Georgetown.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
Lifetime Benefits and Costs of DCCT Intensive Therapy DCCT References: Diabetes Care, : JAMA, :
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
How many …?. What shape can you see? I can see some _____. Q1 Q1 stars.
Glossophobia.
Diabetes type 2 Landmark Outcomes Trials
Volume 20, Issue 7, Pages (July 2017)
Fig. 1. The cumulative incidence of diabetic complication in middle-age-onset and elderly-onset diabetes. (A) Cumulative incidence (%) of coronary revascularization.
From: Pharmacologic Therapy for Type 2 Diabetes Mellitus
THE AREA OF A CIRCLE An introduction to approximating the area of a circle.
Copyright © 2008 American Medical Association. All rights reserved.
The risk of DR progression as related to mean HbA1c during DCCT
Shapes.
The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.
Algorithms.
Selected efficacy and safety parameters.
Cumulative incidence of (A) ESRD, (B) all-cause death, (C) all-cause death without ESRD and (D) ESRD or all-cause death in patients with T1DM diagnosed.
Cumulative incidences of events, according to glucose-control strategy
Cumulative incidence of diabetes for participants in the Diabetes Prevention Program. Cumulative incidence of diabetes for participants in the Diabetes.
Value stream map: direct observation of the baseline transfer process (OR-PACU-PICU, n = 6 patients). Value stream map: direct observation of the baseline.
(A–B) Differences in fat oxidation during the hyperinsulinemic euglycemic clamp between African–American and non-Hispanic white women after 7 days of a.
Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.
Can you work out the next shape in the pattern?
Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs polymorphism and the dietary intervention group after.
Relative effects of glucose-control strategy on microvascular disease.
(A) Glucose values (mean +SEM) during continuous glucose monitoring while consuming whey protein (solid lines and filled circles) or placebo (broken lines.
Shown are cumulative incidence curves of TNNHS and DPT-1 participants who either had DPTRS values >7.00 (A) or dysglycemia (B). Shown are cumulative incidence.
Left columns: Plasma glucose and serum insulin concentrations, circulating TF-PCA, and FVIIa activity before and during 24 h of selective hyperglycemia.
Current insulin dose (units/kg/day) during the DCCT/EDIC study by sex (black line for females) (A), DCCT intensive vs. conventional treatment group (black.
HRs for prostate cancer by medication status.
Pooled risk with 95% CI of ACM (A) and CVD risk (B) for the highest vs
Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.
Scatterplot of the RR estimates of type 2 diabetes reported in the 15 included studies, and the pooled RR estimates with corresponding 95% CIs for five.
Glucose control performance (by CGM) characterized by median and interquartile range cumulative % time in glucose range (A), overall glucose (B), and insulin.
Diabetes development in B6.H-2g7/RIP-B7.1 and control mice.
Baseline predictors of acute complication of diabetes among immigrants with language barriers (N = 87,707). *Adjustment for all variables listed, as well.
Incidence of childhood type 1 diabetes in Western Australia from 1985 through Incidence of childhood type 1 diabetes in Western Australia from 1985.
The Kaplan-Meier curves display the time to event for the primary outcome (A) and total mortality (B) during follow-up from randomization until the end.
The DCCT/EDIC core investigations have been the center of a diverse array of supplemental studies and collaborations over the past 30 years. The DCCT/EDIC.
A: Incidences of all-cause mortality, coronary artery events, and cerebrovascular events by quartiles of baPWV during the follow-up period. A: Incidences.
Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)
SDF-1, adiponectin, and sVCAM levels are higher in Medalists than controls, but SDF-1 does not differ with respect to vascular complications; PAI-1 and.
Cardiorespiratory fitness is associated with SiOGTT, GSISOGTT, and DIOGTT. VO2max was measured during incremental workload and exhaustive aerobic exercise.
Trends in mortality by age-groups and select CVDs among adults with diabetes. Trends in mortality by age-groups and select CVDs among adults with diabetes.
Case report: male 63 years old with documented stenosis of the internal cerebral artery, diabetes duration 12 years, and treatment with 22 IU insulin glargine.
Transaxial sections of contrast-enhanced MRI showing the body and tail of the pancreas (A and B). Transaxial sections of contrast-enhanced MRI showing.
Median (interquartile range) of sensor glucose (A) and insulin delivery (B) during closed-loop (solid red line and red shaded area) and control period.
Pooled analysis of association between (nonexclusive) breast-feeding and childhood-onset type 1 diabetes in studies investigating ∼2 weeks (nonexclusive)
Kaplan-Meier curves of ventricular arrhythmia–related events (A), death from MI (B), or both end points combined (C). Kaplan-Meier curves of ventricular.
Example of how quantitative variables displaying a nonhomogeneous risk in visual display were split in high- and low-risk categories. Example of how quantitative.
One-year cumulative incidence rates of adverse clinical outcomes in 9,428 outpatients with CHF stratified by diabetes status at baseline. One-year cumulative.
A: Probability of retinopathy-free survival.
Trends in age-adjusted diagnosed diabetes prevalence and incidence among adults aged 18–79 years, 1980–2017. Trends in age-adjusted diagnosed diabetes.
Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.
Incidences of transitions between glycemic states by 25-OHD level.
The prevalence of cerebral infarction in the subjects with zero to seven proatherothrombotic alleles. The prevalence of cerebral infarction in the subjects.
Upper panel: For performance of the 10-g monofilament test, the device is placed perpendicular to the skin, with pressure applied until the monofilament.
A: Detection of insulin aspart and insulin lispro by the Iso-insulin ELISA method. A: Detection of insulin aspart and insulin lispro by the Iso-insulin.
2D Shapes Rectangle Circle Triangle Rectangle. What shape is the door? Rectangle.
Incidence rate per 1000 PY of DKA in adults with T1D (reported in eight studies). Submitted as image. Incidence rate per 1000 PY of DKA in adults with.
WM volume did not show the expected increase in volume with age in children with type 1 diabetes (●), in contrast with HC subjects (▲) who showed the (expected)
This is a square. This is a square. How can you tell. How can you tell
The solid line represents the point estimate of the treatment ORs at various levels along the x-axis that ranges from the minimum to the maximum observed.
Can you work out the next shape in the pattern?
Cumulative distributions of A1C and fasting plasma glucose values for the U.S. population aged ≥12 years without diabetes for each survey cycle: 1999–2000,
Cumulative mean numbers of confirmed (plasma glucose ≤3
Sensitivity and specificity of HbA1c, FPG, and 2hPG in identifying persons who developed diabetes within 10 years of screening among children and adolescents.
Presentation transcript:

The cumulative incidence of any major eye disease end point (PDR, CSME, application of laser, or development of blindness) is shown in relation to diabetes duration. The cumulative incidence of any major eye disease end point (PDR, CSME, application of laser, or development of blindness) is shown in relation to diabetes duration. DCCT CON (open squares) and INT (solid circles) groups are presented. Also presented is the cumulative incidence of these major eye disease end points observed in the observational Pittsburgh Epidemiology of Diabetes Complications (EDC) study (solid triangles) (15). Lloyd Paul Aiello, and for the DCCT/EDIC Research Group Dia Care 2014;37:17-23 ©2014 by American Diabetes Association